1.
A real‑world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Paxlovid and Molnupiravir. Human Biology. 2024;94(2):572-580. Accessed November 21, 2024. https://www.humbiol.org/Home/article/view/52